Mrgprb2-mediated mast cell activation exacerbates Modic changes by regulating immune niches

Area of Science:

• Immunology
• Spinal Pathology
• Cell Biology

Background:

• Modic changes are radiographic signs of vertebral endplate inflammation and microfractures.
• Mast cells infiltrate painful degenerated intervertebral discs, but their role in Modic changes is unknown.
• Understanding mast cell involvement is crucial for developing new therapeutic strategies for Modic changes.

Purpose of the Study:

• To investigate the role of mast cells in the development and progression of Modic changes.
• To identify the specific mechanisms and pathways involved in mast cell activation in Modic changes.
• To explore mast cells as a potential therapeutic target for Modic changes.

Main Methods:

• Examined mast cell infiltration in human Modic change samples and mouse models.
• Utilized mast cell-deficient (KITW-SH/W-SH) and Mrgprb2 knockout mice to assess Modic change severity.
• Administered mast cell activator (compound 48/80) and stabilizer (cromolyn) in mouse models.
• Performed transcriptomic sequencing and analyzed immune cell populations (macrophages).

Main Results:

• Increased mast cell infiltration observed in Modic changes.
• Mast cell-deficient mice exhibited significantly reduced Modic change severity.
• Mrgprb2 knockout inhibited mast cell activation and decreased Modic changes.
• Mast cells promote Modic changes by recruiting and polarizing macrophages (M1/M2 imbalance).

Conclusions:

• Mast cells, activated via Mrgprb2, play a significant role in Modic change progression.
• Targeting mast cell activation, particularly through the Mrgprb2 pathway, could be a novel therapeutic approach for Modic changes.
• Modulating mast cell-mediated immune responses in the vertebral endplate offers a promising avenue for treatment.